GLP‑1 Drugs Linked to Nutritional Deficiencies in 1 in 6 Children
Science Daily1 min read98 words
A recent study has highlighted an overlooked risk for children prescribed GLP‑1 medications for weight loss, prediabetes, or type 2 diabetes. The drugs in question include Victoza, Saxenda, Trulicity, and Ozempic.
The research found that nearly one in six young patients developed a diagnosed nutritional deficiency within a year of beginning treatment. Vitamin D deficiency was the most common, affecting about 12 % of the children studied.
These findings indicate that children on GLP‑1 medications for weight or metabolic conditions may be at risk for nutritional deficiencies, with vitamin D deficiency occurring in roughly one‑tenth of the cohort.
Read the original at Science Daily
🤖 AI-generated content — This article was automatically summarised from public RSS feeds by AutoBrief. Verify important information with the original source.